Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

SPINEWAY : LIQUIDITY CONTRACT ANNUAL REPORT
By: Nasdaq / GlobeNewswire - 11 Jan 2019Back to overview list

Press release                                                                                                                                                                       Ecully, 11 January 2019


LIQUIDITY CONTRACT ANNUAL REPORT

Regarding liquidity contract granted by SPINEWAY to PORTZAMPARC, the liquidity account held the following assets on December 31st 2018:

  • 87,655 shares SPINEWAY,
  • 6,247.50 €.

At June 30th 2018 report, the position of this liquidity contract was:

  • 37,149 shares SPINEWAY,
  • 13,599.91 €.

Next communication: 2018 full year sales – January 16, 2019 after market closing

SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES)
Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) – Talent INPI award (2015).
ISIN code: FR0011398874 - ALSPW     

SPINEWAY
 AELIUM Finance et Communication
Investor Relations
David Siegrist – Finance Director
Tel: +33 (0)4 72 77 01 52
finance.dsg@spineway.com
 Financial Communication
Jérôme Gacoin / Solène Kennis
Tel: +33 (0)1 75 77 54 68
skennis@aelium.fr

Attachment

Related companies:Spineway
Copyright 2019 Nasdaq / GlobeNewswire Back to overview list
to the top ↑